Advancing pharmacovigilance through analysis of a gadolinium-based contrast agent (GBCA) exposure dataset for nephrogenic systemic fibrosis: A RADAR report - 07/03/12
Beatrice Nardone, MD, PhD, Department of Dermatology, Northwestern University, Chicago, IL, United States; Anne E. Laumann, MBChB, Department of Dermatology, Northwestern University, Chicago, IL, United States; Beatrice J. Edwards, MD, MPH, Department of Medicine, Division of Geriatrics, Northwestern University, Chicago, IL, United States; Dennis P. West, PhD, Department of Dermatology, Northwestern University, Chicago, IL, United States; Steven M. Belknap, MD, Department of Dermatology, Northwestern University, Chicago, IL, United States
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 66 - N° 4S1
P. AB5 - avril 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?